Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...
The "INSIGHT" trial: An explorative, open-labeled phase I study to evaluate the feasibility and safety of intra-tumoral, intra-peritoneal, and subcutaneous injections with IMP321 (LAG-3Ig fusion ...